February 29, 2008 (Seattle) – In a victory for pro-life families around the world, AVM Biotechnology LLC (AVM Biotech) today announced their decision to provide ethical alternatives in the fields of biotechnology, pharmaceuticals, and vaccine development.

Dr Theresa Deisher, AVM Biotech Research and Development Director and founder stated, “We will be working to bring commercially available, morally acceptable, vaccines to the US market and to use existing technology to produce new morally certified vaccines. Revenues from the vaccine business will also further the research, development and commercialization of morally certified therapeutics in other areas of medicine as well.”

The announcement was an answer to years of hard work and prayers for Children of God for Life, a pro-life organization that has battled to bring moral alternatives to aborted fetal vaccines to the US market for nearly a decade…

While most vaccines and medicines are produced in an ethical manner, several are manufactured using cell lines derived from aborted fetal tissue with no competing ethical products available. Vinnedge noted this has left concerned pro-life families in both a difficult and unjust position…

AVM Biotech intends to further assist in this effort by certifying that its therapeutic products are not discovered, screened, evaluated, produced, or tainted in any way by the use of electively aborted human fetal material, human embryonic material, or any other unethically obtained materials.

More… (source)

Advertisements